• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

East of England NHS Genomic Medicine Centre

Using genetics to personalize your care

  • HOME
    • News
  • ABOUT
  • Ask
    • Your Questions Answered
      • 100,000 Genomes Project
      • Confidentiality and Ethics
      • Genetics and Genomics
      • Genetics and Inheritance
      • Genetic Manipulation
      • Governance around supporting Patients and the Public
      • Impact of environment and behaviour on cancer
      • NHS provision for cancer, inherited disease and infectious diseases
      • Talking to Families
      • When testing identifies variations…
  • 100,000 Genomes Project
    • Patients
      • I have cancer…
      • I have a rare disease…
      • How to get referred
      • My doctor wants to refer me
      • Your data questions answered
      • Key Documents
      • FAQs
      • Information & Consent Form
      • Perspectives
        • A parent’s perspective
        • Helen’s story
        • Katy’s story
        • Mary, Sandra and Kerry’s story
    • Healthcare Professionals
      • Recruiting one of your patients
      • Referrals
      • What is Phenotyping?
      • Key Documents
    • Approved conditions
    • Approved List of Cancers
    • Eligibility statements
  • Tests
    • Genetic Test Resources
    • Genetic Disorders
    • Prenatal
    • Newborn Screening
    • Drug Response
    • Transplants
    • Infectious Disease
    • Laboratories
      • Cambridge Laboratories
        • Biochemistry
        • Genetic
        • Haematology Oncology
        • Histocompatability
        • Microbiology
        • Thrombo
      • Leicester (CytoGenetics)
      • Norwich (Molecular Genetics)
      • Nottingham
  • Education
    • Cambridge Genomics
      • Taught courses for CPPD
      • Train as a Genetic Counsellor
      • Degree & Awards
    • Leicester Genomics
    • National Programme
    • Train as a Clinical Geneticist
    • Train as a Genetic Counsellor
    • Train as a Healthcare Scientist
    • Online courses
    • Other Opportunities
      • Student4RareDisease
      • European Molecular Biology Lab
    • Schools
  • Care
    • Cambridge/East Anglia
      • Referral
      • Team
      • Clinics
    • Leicester
      • Referral
      • Team
      • Clinics
    • Norwich
      • Referral
      • Team
      • Clinics
    • Nottingham
      • Referral
      • Team
      • Clinics
  • Resources
    • Films and Books
    • Leaflets,Posters & Flyers
    • Genomics in Mainstream Medicine
    • Guide to genetic Test Report
    • DNA Learning Centre
  • Groups
    • Patient Groups / Advocacy
    • Research
    • Policy
    • Innovation

Talking to Families

  • Twitter
You are here: Home / Ask / Your Questions Answered / Talking to Families

Who normally has access to a patient’s genetic data?
What are the key challenges around patient confidentiality that Clinical Geneticists face?
In what two main areas is sharing of patient information required?
How are these two scenarios best tackled?
What are the more particular challenges?
How should genetic information be given?


Who normally has access to a patient’s genetic data?
Only doctors, nurses and other healthcare professionals in NHS Genomic Medicine Centres have access to information about the patients they are caring for.


What are the key challenges around patient confidentiality that Clinical Geneticists face?
As a number of conditions are more common in the same family, one of the key differences between clinical genetics and other specialities is that clinical genetics often involves coordinating care for more than one individual. This can aid finding the cause of disease and protecting at-risk relatives but can be challenging, as everybody is entitled to their own confidentiality and the NHS is rarely set up to support more than one patient in the same clinical episode.


In what two main areas is sharing of patient information required?

  1. Where a mutation has been identified and close relatives (parents, siblings and children) are eligible for a blood test to determine their risk of developing the same or related disease.
  2. Where no mutation has been identified but other relatives might either benefit from a genetic test or are eligible for screening to detect disease at an earlier stage.


How are these two scenarios best tackled?
Through a generic letter for at-risk relatives to be sent by clinical genetics to the original patient to pass onto their family as appropriate. The at-risk relative is signposted to their own general practitioner to discuss the relative merits of a referral for either genetic testing or screening.


What are the more particular challenges?

  • When to discuss things with children
  • How best to provide information when family relationships have broken down
  • Finding out who is best placed to coordinate information in large families (‘the family gate-keeper’).


How should genetic information be given?
There are no hard and fast rules to this but there are a few guiding principles that may help genetic counsellors frame these for relatives:

  • Be mindful so you don’t project a negative or fearful approach to relatives, as this may profoundly effect how the disease and its risk is perceived.
  • On occasion the affected patient may not be the best person to disclose this information to relatives and it may be easier and less stressful for all if another family member fulfils this role.
  • Genetic testing is often most usefully discussed at a time when the result can be meaningfully acted upon, for example at screening visits or when prevention strategies or family planning can be offered now.
  • Try to avoid stressful periods of time for testing if clinically time is not going to effect decisions or care e.g. avoid examination periods, beginning of the first year of university or around a new diagnosis.
  • Where relationships are strained signposting by letter to clinical services may be more appropriate and less stressful for all concerned.
  • Let children come to you to discuss the disease and their feelings and talk about genetics.

Ultimately If you do not see your questions being answered in this specific section, please check the rest of the other section and if you still can not find your question answered then please do send us your questions to our Ask page.

Go top

Primary Sidebar

Recent Posts

  • Regional Cancer Care Events March 20, 2018
  • 100,000 Genomes Project Update March 20, 2018
  • Avatars to the rescue for new mums March 20, 2018
  • Education and training August 31, 2017
  • Patients Know Best? August 23, 2017
  • Home

RSS News from the University of Cambridge

  • Prehistoric humans are likely to have formed mating networks to avoid inbreeding October 5, 2017
    The study, reported in the journal Science, examined genetic information from the remains of anatomically modern humans who lived during the Upper Palaeolithic, a period when modern humans from Africa first colonised western Eurasia. The results suggest that people deliberately sought partners beyond their immediate family, and that they were probably connected to a wider […]
  • Genome editing reveals role of gene important for human embryo development September 20, 2017
    The team used genome editing techniques to stop a key gene from producing a protein called OCT4, which normally becomes active in the first few days of human embryo development. After the egg is fertilised, it divides until at about 7 days it forms a ball of around 200 cells called the ‘blastocyst’. The study […]
  • Snip, snip, cure: correcting defects in the genetic blueprint July 14, 2017
    Dr James Thaventhiran points to a diagram of a 14-year-old boy’s family tree. Some of the symbols are shaded black. “These family members have a very severe form of immunodeficiency. The children get infections and chest problems, the adults have bowel problems, and the father died from cancer during the study. The boy himself had […]

Want to find out more?

  • Contact

Copyright © 2018 · Showcase Pro on Genesis Framework · WordPress · Log in